Welcome to CDC stacks | Laboratory biosafety guidelines for handling and processing specimens associated with SARS-CoV - 24825 | Stephen B. Thacker CDC Library collection
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
Clear All Simple Search
Advanced Search
Laboratory biosafety guidelines for handling and processing specimens associated with SARS-CoV
  • Published Date:
    January 8, 2004
  • Source:
    Severe acute respiratory syndrome
    Public health guidance for community-level preparedness and response to severe acute respiratory syndrome (SARS) Version 2. Supplement F: Laboratory guidance appendix F5
  • Language:
Filetype[PDF-88.98 KB]

  • Corporate Authors:
    Centers for Disease Control and Prevention (U.S.)
  • Description:
    Although routine clinical laboratories around the world have processed an estimated several thousand diagnostic specimens from patients with SARS, no cases of SARS-CoV disease among laboratory workers performing diagnostic assays have been reported to date. However, there have been two reported cases of SARS-CoV disease in workers in research laboratories where SARS-CoV was being propagated. Until more information about the transmission of SARS-CoV in the laboratory setting is known, precautions should be taken in handling specimens (e.g., respiratory and stool specimens, unfixed lung tissue, viral cultures) that might contain large quantities of SARS-CoV.

    Effective and timely communication between clinical and laboratory staff is essential to minimize the risk incurred in handling specimens from patients with possible SARS-CoV disease. Such specimens should be labeled accordingly, and the laboratory should be alerted to ensure proper specimen handling. Biosafety guidelines for handling SARS-CoV specimens, by specimen type, are provided below.

  • Supporting Files:
    No Additional Files
No Related Documents.
You May Also Like: